Processing

Please wait...

Settings

Settings

1. WO1991000091 - USE OF NORVERAPAMIL AND NORGALLOPAMIL AS ANTI-ARTERIOSCLEROSIS DRUGS

Publication Number WO/1991/000091
Publication Date 10.01.1991
International Application No. PCT/EP1990/001031
International Filing Date 27.06.1990
Chapter 2 Demand Filed 13.12.1990
IPC
A61K 31/275 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
275Nitriles; Isonitriles
CPC
A61K 31/275
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
275Nitriles; Isonitriles
Y10S 514/824
YSECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
10TECHNICAL SUBJECTS COVERED BY FORMER USPC
STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
514Drug, bio-affecting and body treating compositions
824Arteriosclerosis
Applicants
  • KNOLL AKTIENGESELLSCHAFT [DE/DE]; Knollstrasse D-6700 Ludwigshafen, DE (AllExceptUS)
  • MUELLER, Claus, D. [DE/DE]; DE (UsOnly)
  • UNGER, Liliane [DE/DE]; DE (UsOnly)
Inventors
  • MUELLER, Claus, D.; DE
  • UNGER, Liliane; DE
Agents
  • KARAU, Wolfgang; BASF Aktiengesellschaft Carl-Bosch-Strasse 38 D-67056 Ludwigshafen, DE
Priority Data
P 39 21 006.527.06.1989DE
Publication Language German (DE)
Filing Language German (DE)
Designated States
Title
(DE) VERWENDUNG VON NOR-VERAPAMIL UND NOR-GALLOPAMIL ALS ANTIARTERIOSKLEROTICA
(EN) USE OF NORVERAPAMIL AND NORGALLOPAMIL AS ANTI-ARTERIOSCLEROSIS DRUGS
(FR) UTILISATION DE NOR-VERAPAMIL ET DE NOR-GALLOPAMIL EN TANT QU'AGENTS ANTI-ARTERIOSCLEREUX
Abstract
(DE)
Verwendung von Nor-Verapamil und Nor-Gallopamil und deren Salzen mit physiologisch verträglich Säuren zur Herstellung von Arzneimitteln mit antiarteriosklerotischen Eigenschaften.
(EN)
Disclosed is the use of norverapamil and norgallopamil, and their salts with physiologically compatible acids, for the preparation of drugs with anti-arteriosclerosis properties.
(FR)
On utilise du nor-verapamil et du nor-gallogamil, ainsi que leurs sels, avec des acides physiologiquement compatibles, afin de produire des médicaments à propriétés anti-artérioscléreuses.
Also published as
Other related publications
Latest bibliographic data on file with the International Bureau